Literature DB >> 32158931

PSPC1: a contextual determinant of tumor progression.

Yaw-Dong Lang1, Yuh-Shan Jou1.   

Abstract

Protein-tyrosine kinase 6 (PTK6) sequestrated by its substrate paraspeckle component 1 (PSPC1) in nucleus is a tumor suppressor. PSPC1 functions as a contextual determinant of oncogenic subcellular translocations to synergize PSPC1/β-catenin and PTK6 tumorigenesis. Besides, PSPC1 C-terminal interacting domain (PSPC1-CT131), a dual inhibitor of PSPC1 and PTK6, suppresses cancer progression.
© 2020 Taylor & Francis Group, LLC.

Entities:  

Keywords:  CSC; EMT; HCC; Oncogenic subcellular translocation; metastasis

Year:  2020        PMID: 32158931      PMCID: PMC7051164          DOI: 10.1080/23723556.2020.1721253

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  8 in total

1.  Redefining Biology via Enzyme Engineering.

Authors:  Mirna Kvajo
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

2.  PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis.

Authors:  Hsi-Wen Yeh; En-Chi Hsu; Szu-Shuo Lee; Yaw-Dong Lang; Yuh-Charn Lin; Chieh-Yu Chang; Suz-Yi Lee; De-Leung Gu; Jou-Ho Shih; Chun-Ming Ho; Chian-Feng Chen; Chiung-Tong Chen; Pang-Hsien Tu; Ching-Feng Cheng; Ruey-Hwa Chen; Ruey-Bing Yang; Yuh-Shan Jou
Journal:  Nat Cell Biol       Date:  2018-03-28       Impact factor: 28.824

Review 3.  A New Switch for TGFβ in Cancer.

Authors:  Hsi-Wen Yeh; Szu-Shuo Lee; Chieh-Yu Chang; Yaw-Dong Lang; Yuh-Shan Jou
Journal:  Cancer Res       Date:  2019-07-12       Impact factor: 12.701

Review 4.  Cell motility in cancer invasion and metastasis: insights from simple model organisms.

Authors:  Christina H Stuelten; Carole A Parent; Denise J Montell
Journal:  Nat Rev Cancer       Date:  2018-03-16       Impact factor: 60.716

Review 5.  Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling.

Authors:  Fabio Conforti; Yisong Wang; Jose A Rodriguez; Anna Teresa Alberobello; Yu-Wen Zhang; Giuseppe Giaccone
Journal:  Clin Cancer Res       Date:  2015-08-31       Impact factor: 12.531

Review 6.  EMT Transition States during Tumor Progression and Metastasis.

Authors:  Ievgenia Pastushenko; Cédric Blanpain
Journal:  Trends Cell Biol       Date:  2018-12-26       Impact factor: 20.808

7.  An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.

Authors:  Anna Bafico; Guizhong Liu; Luba Goldin; Violaine Harris; Stuart A Aaronson
Journal:  Cancer Cell       Date:  2004-11       Impact factor: 31.743

8.  PSPC1 potentiates TGF-β-dependent metastatic dissemination.

Authors:  Hsi-Wen Yeh; Yuh-Shan Jou
Journal:  Mol Cell Oncol       Date:  2018-08-01
  8 in total
  5 in total

Review 1.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

2.  PSPC1 Potentiates IGF1R Expression to Augment Cell Adhesion and Motility.

Authors:  Hsin-Wei Jen; De-Leung Gu; Yaw-Dong Lang; Yuh-Shan Jou
Journal:  Cells       Date:  2020-06-18       Impact factor: 6.600

3.  The Prognosis Value of PSPC1 Expression in Nasopharyngeal Cancer.

Authors:  Huocong He; Lurong Zhang; Keyu Lin; Zhengrong Huang; Yan Zhou; Shaojun Lin; Ying Su; Jianru Pan
Journal:  Cancer Manag Res       Date:  2021-04-14       Impact factor: 3.989

Review 4.  RNA-Binding Proteins in the Regulation of Adipogenesis and Adipose Function.

Authors:  Pengpeng Zhang; Wenyan Wu; Chaofeng Ma; Chunyu Du; Yueru Huang; Haixia Xu; Cencen Li; Xiaofang Cheng; Ruijie Hao; Yongjie Xu
Journal:  Cells       Date:  2022-07-31       Impact factor: 7.666

Review 5.  PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression.

Authors:  Yaw-Dong Lang; Yuh-Shan Jou
Journal:  J Biomed Sci       Date:  2021-08-02       Impact factor: 8.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.